Tech Company Financing Transactions

Promedior Funding Round

Easton Capital, Forbion Capital Partners and HealthCare Ventures participated in a $21.5 million Series D funding round for Promedior. The financing round was announced on 3/8/2012.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

101 Hartwell Ave.
Lexington, MA 02421
USA

Phone

(781) 538-4200

Website

www.promedior.com

Email Address

[email protected]

Overview

Promedior is a product-focused biopharmaceutical company developing novel therapeutics for the treatment of fibrotic disorders and diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Russell Ellison

        

Chief Medical Officer

Bernt Blink

        

Chief Medical Officer

Renu Gupta

        

Chief Operating Officer

Richard Jack

        

VP - Bus. Development

Scott Willett

        

Browse more venture capital transactions:

Prev: 3/8/2012: HipChat venture capital transaction
Next: 3/8/2012: Raditaz venture capital transaction

Share this article

News on VC Transactions

Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary